These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20014988)

  • 1. Adjuvant therapy for atrial fibrillation.
    Mohammed KS; Kowey PR; Musco S
    Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the management of atrial fibrillation: focus on current guidelines and the impact of new agents on future recommendations.
    Naccarelli GV; Curtis AB
    J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):244-56. PubMed ID: 20562374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
    Lally JA; Gnall EM; Seltzer J; Kowey PR
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
    Savelieva I; Camm J
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-antiarrhythmic drugs to prevent atrial fibrillation.
    Moro C; Hernández-Madrid A; Matía R
    Am J Cardiovasc Drugs; 2010; 10(3):165-73. PubMed ID: 20524718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
    Chávez LL
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I; John Camm A
    Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstream effect for atrial fibrillation: still a dilemma?
    Calò L; Martino A; Sciarra L; Ciccaglioni A; De Ruvo E; De Luca L; Sette A; Giunta G; Lioy E; Fedele F
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):111-28. PubMed ID: 21029134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of atrial fibrillation.
    Bajpai A; Savelieva I; Camm AJ
    Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmaceutical pipeline for atrial fibrillation.
    Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
    Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.
    Mayson SE; Greenspon AJ; Adams S; Decaro MV; Sheth M; Weitz HH; Whellan DJ
    Cardiol Rev; 2007; 15(5):231-41. PubMed ID: 17700382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical update on the management of atrial fibrillation.
    Danelich IM; Reed BN; Hollis IB; Cook AM; Rodgers JE
    Pharmacotherapy; 2013 Apr; 33(4):422-46. PubMed ID: 23553811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
    Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
    Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers.
    Davis EM; Packard KA; Hilleman DE
    Pharmacotherapy; 2010 Jul; 30(7):749, 274e-318e. PubMed ID: 20575638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-antiarrhythmic drug therapy for the prevention of atrial fibrillation?].
    Fauchier L; Zannad N; Clementy N; Pierre B; Cosnay P; Babuty D
    Ann Cardiol Angeiol (Paris); 2010 Dec; 59 Suppl 1():S28-32. PubMed ID: 21211623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.